Endocryne, with its slogan "Mining Natural Therapeutics," is a biotechnology startup that was founded in 2019. The company describes itself as pioneers in Synthetic Biology, focused on mining and developing natural therapeutics. Specializing in the industries of Biotechnology and Sustainability, Endocryne has attracted attention in the field of healthcare and environmental sustainability. Although the exact location of its headquarters is not specified, the potential for innovation in this space is promising. As of now, there is no public record of its last investment or the involved investors. Given the burgeoning interest in biotechnology and sustainability, Endocryne's unique approach holds significant potential for disruption and market impact. With its focus on natural therapeutics and synthetic biology, the startup is poised to make significant strides in addressing healthcare and environmental challenges.
There is no investment information
No recent news or press coverage available for Endocryne.